MiNK Therapeutics Inc.

NASDAQ: INKT · Real-Time Price · USD
14.90
-0.05 (-0.33%)
At close: Aug 22, 2025, 3:59 PM
15.00
0.67%
After-hours: Aug 22, 2025, 07:28 PM EDT

MiNK Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-11.27M -9.74M -10.78M -13.78M -17.09M -20.59M -22.46M -24.77M -25.98M -25.9M -27.99M -25.99M -33.92M -34.14M -30.21M -25.98M -17.76M -15.75M
Depreciation & Amortization
216.03K 212.37K 215.44K 215.14K 205.96K 212.76K 204.62K 188.98K 163.96K 140.36K 121.75K 107.65K 99.5K 88.84K 77.96K 70.26K 64.81K 59.21K
Stock-Based Compensation
2.76M 2.3M 2.3M 3.01M 3.07M 3.53M 3.86M 3.43M 3.26M 3.16M 3.03M 3.03M 2.64M 2.25M 1.74M 1.11M 735.35K 349.45K
Other Working Capital
1.57M 1.26M 1.64M 3.68M 3.38M 5.66M 4.81M 5.24M 4.18M 4.18M 6.11M 6.01M 7.8M 6.43M 3.89M 1.12M -357.74K -537.07K
Other Non-Cash Items
-1.34B -1.34B -1.75M -478.15K 656.82K 381.25K 1.24M 5.98B 5.98B 5.98B 5.98B -2.19M 7.56M 12.32M 12.18M 13.89M 7.41M 6.79M
Deferred Income Tax
n/a n/a n/a -1.58M -643.18K -643.18K -1.5M -5.98B -5.98B -5.98B -5.98B -349.59K -355.51K -355.51K -355.51K -355.51K n/a n/a
Change in Working Capital
1.68M 429.97K 459.73K 1.75M 1.72M 3.17M 2.9M 4.26M 4.26M 6.35M 8.77M 9.45M 10.15M 7.23M 3.74M -1.58M -2.38M -1.98M
Operating Cash Flow
-1.35B -1.35B -9.56M -10.86M -12.08M -13.94M -15.76M -17.16M -18.56M -19.04M -18.87M -16.14M -14.02M -12.81M -12.83M -12.84M -11.93M -10.53M
Capital Expenditures
n/a n/a -3 73.56K 50.52K 13.5K n/a -201.4K -238.15K -263.55K -250.05K -121.93K -173.96K -209.46K -248.98K -249.26K -137.44K -87.13K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -73.56M -73.56M -73.56M -87.06M -263.55M -263.55M -263.55M -250.05M -248.98M -248.98M -248.98M -248.98M n/a n/a n/a
Investing Cash Flow
n/a n/a n/a -73.49M -73.51M -73.55M -73.56M -201.4K -238.15K -263.55K -250.05K -121.93K -173.96K -209.46K -248.98K -249.26K -137.44K -87.13K
Debt Repayment
-5M -5M n/a 5M 5M 5M n/a n/a n/a n/a n/a -76 2.78M 7.13M 9.46M 12.79M 12.54M 8.19M
Common Stock Repurchased
-3 -3 -3 n/a n/a -97.72K -477.64K -634.83K -634.83K -694.31K -314.39K -157.19K -157.19K n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
5.58M 5.58M 5.01M 6.29K 9.24K 24.97K 70.47K 70.58K 68.12K 46.4K 1.59K 39.8M 39.8M 39.8M 39.8M 150.00 350.00 2.62M
Financial Cash Flow
583.34K 6.39M 10.82M 10.82M 10.82M 4.93M -407.17K -407.06K -409.52K -490.71K -155.6K 39.64M 42.42M 46.93M 49.26M 12.79M 12.54M 10.81M
Net Cash Flow
-1.35B -1.34B 1.21M -70.61K -1.31M -9.07M -16.27M -17.76M -19.22M -19.8M -19.25M 23.34M 28.19M 33.88M 36.2M -467.59K 287.42K -24.71K
Free Cash Flow
-1.35B -1.35B -9.56M -10.79M -12.03M -13.92M -15.76M -17.36M -18.8M -19.3M -19.12M -16.26M -14.19M -13.02M -13.08M -13.09M -12.07M -10.61M